Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 3
1960 2
1961 3
1962 1
1963 3
1966 5
1967 3
1968 2
1969 3
1970 2
1971 4
1972 1
1973 5
1974 9
1975 11
1976 12
1977 5
1978 7
1979 13
1980 21
1981 20
1982 18
1983 19
1984 15
1985 14
1986 5
1987 10
1988 8
1989 9
1990 7
1991 5
1992 6
1993 4
1994 8
1995 3
1996 1
1997 1
1998 4
1999 4
2000 1
2001 3
2002 2
2003 5
2004 5
2005 3
2006 2
2007 7
2008 9
2009 11
2010 6
2011 4
2012 4
2013 8
2014 12
2015 9
2016 5
2017 11
2018 11
2019 25
2020 26
2021 27
2022 16
2023 13
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

492 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Perinatal morbidity among women with a previous caesarean delivery (PRISMA trial): a cluster-randomised trial.
Chaillet N, Mâsse B, Grobman WA, Shorten A, Gauthier R, Rozenberg P, Dugas M, Pasquier JC, Audibert F, Abenhaim HA, Demers S, Piedboeuf B, Fraser WD, Gagnon R, Gagné GP, Francoeur D, Girard I, Duperron L, Bédard MJ, Johri M, Dubé E, Blouin S, Ducruet T, Girard M, Bujold E; PRISMA Trial research group. Chaillet N, et al. Lancet. 2024 Jan 6;403(10421):44-54. doi: 10.1016/S0140-6736(23)01855-X. Epub 2023 Dec 11. Lancet. 2024. PMID: 38096892 Clinical Trial.
Early neonatal death: A challenge worldwide.
Lehtonen L, Gimeno A, Parra-Llorca A, Vento M. Lehtonen L, et al. Among authors: gimeno a. Semin Fetal Neonatal Med. 2017 Jun;22(3):153-160. doi: 10.1016/j.siny.2017.02.006. Epub 2017 Feb 24. Semin Fetal Neonatal Med. 2017. PMID: 28238633 Review.
Glycans in Infectious Diseases. A Molecular Recognition Perspective.
Unione L, Gimeno A, Valverde P, Calloni I, Coelho H, Mirabella S, Poveda A, Arda A, Jimenez-Barbero J. Unione L, et al. Among authors: gimeno a. Curr Med Chem. 2017 Nov 24;24(36):4057-4080. doi: 10.2174/0929867324666170217093702. Curr Med Chem. 2017. PMID: 28215157 Review.
Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition.
Macip G, Garcia-Segura P, Mestres-Truyol J, Saldivar-Espinoza B, Ojeda-Montes MJ, Gimeno A, Cereto-Massagué A, Garcia-Vallvé S, Pujadas G. Macip G, et al. Among authors: gimeno a. Med Res Rev. 2022 Mar;42(2):744-769. doi: 10.1002/med.21862. Epub 2021 Oct 26. Med Res Rev. 2022. PMID: 34697818 Free PMC article. Review.
Diagnostic delay in monogenic disease: A scoping review.
Tinker RJ, Fisher M, Gimeno AF, Gill K, Ivey C, Peterson JF, Bastarache L. Tinker RJ, et al. Among authors: gimeno af. Genet Med. 2024 Apr;26(4):101074. doi: 10.1016/j.gim.2024.101074. Epub 2024 Jan 17. Genet Med. 2024. PMID: 38243783 Free PMC article. Review.
Targeting Galectins With Glycomimetics.
Bertuzzi S, Quintana JI, Ardá A, Gimeno A, Jiménez-Barbero J. Bertuzzi S, et al. Among authors: gimeno a. Front Chem. 2020 Aug 7;8:593. doi: 10.3389/fchem.2020.00593. eCollection 2020. Front Chem. 2020. PMID: 32850631 Free PMC article. Review.
Glycans in drug discovery.
Valverde P, Ardá A, Reichardt NC, Jiménez-Barbero J, Gimeno A. Valverde P, et al. Among authors: gimeno a. Medchemcomm. 2019 Jul 26;10(10):1678-1691. doi: 10.1039/c9md00292h. eCollection 2019 Oct 1. Medchemcomm. 2019. PMID: 31814952 Free PMC article. Review.
492 results